SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLASs guidance that topline results from its Phase 3 REGAL trial of GPS in AML are expected this month, following the trials 80th event, has focused attention on the upcoming readout and coincided with a sharp after-hours move. Bulls are anticipating a successful result and discussing a possible short squeeze, while others caution that the data remain unreleased and speculation about a leak is unconfirmed.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,111,281. The last known price of Bitcoin is 71,086.72423286 USD and is down -3.89 over the last 24 hours. It is currently trading on 12779 active market(s) with $28,515,435,687.36 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins steep selloff and break below a closely watched support area dominate the discussion, with traders pointing to leveraged liquidations and broader risk-off selling. The community is split between expecting further downside and treating the drop as an oversold buying opportunity.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

A widespread Microsoft 365 outage disrupting Outlook, Teams, Copilot and other services is dominating discussion, with users describing work interruptions and traders questioning the hit to reliability and reputation. Some speculate about a cyberattack, but that remains unconfirmed; others are surprised the shares held relatively steady despite the disruption.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candels FDA discussions over assay refinement have pushed the planned prostate-cancer BLA filing to mid-2027, prompting a sharp selloff and concern about the longer regulatory timeline. Traders disagree on whether this is a fixable manufacturing-and-testing delay that leaves the clinical data intact or a sign of broader execution problems; criticism of management and trust has intensified, while some investors remain confident in the science.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Ciscos quarterly earnings beat and raised outlook, driven by demand for AI-data-center networking, are the main focus. Traders see potential in a longer-term networking cycle but are frustrated by the muted, volatile share reaction and debate margin pressure, backlog trends, and whether AI orders will translate into durable revenue.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius is under pressure after its Q3 report paired strong growth with a 2026 revenue outlook at the low end of its range, capacity delays, and sharply higher planned capital spending. Traders are split between those emphasizing AI demand and customer prepayments and those worried about execution, financing needs, and when the added capacity will generate revenue.

Zoom Communications, Inc. engages in the provision of a communications and collaboration platform. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa. The company was founded by Eric S. Yuan in 2011 and is headquartered in San Jose, CA.

Zoom Communications Inc. - Ordinary Shares - Class A

Anthropics reported confidential IPO filing has renewed attention on Zooms early investment in the AI company, with traders debating how much value the stake could add; bullish posts also point to Zooms enterprise and AI momentum, while skeptics question whether that offsets modest core growth and competition.

On Holding AG engages in the development and distribution of sports products such as footwear, apparel, and accessories for high-performance running, outdoor, all-day activities, and tennis. It sells its products worldwide through independent retailers and global distributors, its own online presence, and its own stores. The company was founded by David Allemann, Olivier Bernhard, and Caspar Coppetti in January 2010 and is headquartered in Zurich, Switzerland.

On Holding AG - Ordinary Shares Class A

On Holding AG

On Holdings Q3 earnings are driving attention: traders are weighing a reported beat and higher gross-margin outlook against softer direct-to-consumer growth and full-year guidance that was reiterated. Some see the selloff as a buying opportunity, while others question the quality of the beat because tariff refunds boosted reported margins.

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell is caught in a volatile AI-hardware and data-center selloff, with traders pointing to Intels warning on PC demand and broader concerns about capex financing, server margins, and uncertainty around data-center expansion. Bulls see the drop as an overreaction and cite continued AI-server demand, while bears argue that thin-margin sales to debt-funded customers make that demand vulnerable.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

RUMs quarterly resultsrecord revenue growth and its first positive adjusted EBITDA, driven largely by Quake AIs GPU-cloud businesshave focused attention on its shift toward AI infrastructure. Bulls point to strong demand and high short interest, while skeptics question the cash and financing needed for the Maysville data-center expansion and whether it can be delivered on schedule.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Here's Why You Should Retain CONMED Stock in Your Portfolio for Now

CONMED's AirSeal, Buffalo Filter and BioBrace platforms offer growth opportunities, while rising robotic procedures and ASC adoption support its long-term prospects despite tariff and operational headwinds.

CONMED Corporation to Participate in the Jefferies Global Healthcare Conference

CONMED Corporation (NYSE: CNMD) today announced its participation in the Jefferies Global Healthcare Conference, which is being held November 16-19, 2026 at the Waldorf Hilton and ME Hotel in London, UK. Management will participate in a fireside chat on Monday, November 16th at 11:30 a.m. Greenwich...

Conmed (CNMD) Q3 Earnings Top Estimates

Conmed (CNMD) delivered earnings and revenue surprises of +4.00% and -0.37%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Here's What Key Metrics Tell Us About Conmed (CNMD) Q3 Earnings

While the top- and bottom-line numbers for Conmed (CNMD) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

CONMED Q3 Profit Rises, Updates 2026 Guidance

(RTTNews) - CONMED Corporation (CNMD) on Wednesday, reported higher net income for the third quarter of 2026 compared with the same period a year earlier, despite a slight decline in net sales...

CONMED Corporation Reports Third Quarter 2026 Financial Results; Updates Full Year 2026 Guidance

CONMED Corporation (NYSE: CNMD) today reported financial results for the third quarter ended September 30, 2026 and updated its financial guidance for the full year ending 2026. Third Quarter 2026 Highlights(1) Sales of $335.6 million decreased 0.7% year-over-year as reported and decreased 0.8% on...

CONMED Corporation to Report Third Quarter 2026 Financial Results on October 28, 2026

CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the third quarter 2026 after the market close on Wednesday, October 28, 2026. The Companys management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the...

CONMED's BioBrace and AirSeal platforms, robotic growth and easing supply bottlenecks support its long-term outlook despite tariff headwinds.

CNMD Crosses Above Average Analyst Target

In recent trading, shares of CONMED Corp (Symbol: CNMD) have crossed above the average analyst 12-month target price of $46.43, changing hands for $46.95/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuatio...

Is Cardinal Health Building a New Tech-Enabled Healthcare Platform?

Technology is becoming a bigger part of CAH's strategy, linking distribution, specialty services and logistics through digital workflows.

• Reported GAAP EPS of $1.04 down -3.70% YoY
• Reported revenue of $335.56M down -0.70% YoY
• CONMED expects to repurchase approximately $62M in 2026 under its authorized share repurchase program; no quantified revenue, margin, or earnings outlook is provided in this filing.

CONMED's net sales decreased 0.7%; general surgery sales decreased 6.5%, primarily due to the gastroenterology exit; interest expense increased from $7.6M to $11.1M, alongside ongoing supply chain challenges.

CONMED's orthopedic surgery sales increased 7.7% with growth in sports medicine, visualization and BioBrace; gross profit margins increased to 56.4%, and net income was $19.8M versus $2.9M.

CONMED Corp. is a medical technology company, which engages in providing devices and equipment for surgical procedures. Its products include AirSeal and insufflation, allograft cartilage and tissue, arthroplasty, biliary and endoscopic ultrasound, biomedical sensors and electrodes, biopsy and polypectomy, dilators and accessories, electrosurgical units, fixation devices, hemostasis, implants and suture anchors, infection prevention, patient positioning, and related products. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Largo, FL.

Conmed Corp.

CNMD Stock Hits Highest Level In Over Four Months – Why JPMorgan Believes Firm Would Be Highly Attractive To ‘Financial Acquirers’ 

Equity

Neutral Sentiment

<ul class="summary-bullets"><li>JPMorgan believes Conmed’s fundamentals would make it "look highly attractive to financial acquirers."</li><li>Needham opined that a Conmed sale makes sense given its mid-single-digit growth, "strong recurring revenue composition, and depressed valuation."</li><li>For the first quarter, the company reported revenue of $317 million and adjusted earnings per share of $0.89.</li></ul>Shares of Conmed (CNMD) attracted significant investor attention on Monday after analysts commented on the reported buyout interest received by the medical technology company last week.At the time of writing, CNMD shares shot up more than 10%, hitting a four-month high.On Friday, a Bloomberg Law report indicated that the company is considering a sale and working with advisers to explore strategic options after private equity investors expressed interest in acquiring it.<h2 class="st-heading-2">JPMorgan’s Take On Conmed</h2>JPMorgan said Conmed’s fundamentals "likely make it less attractive" to a strategic buyer, but its free cash flow yield and "clean financials" would make it "look highly attractive to financial acquirers," and it could fit into a broader portfolio of orthopedic products, according to TheFly.JPMorgan said it is "hopeful" that Conmed is on an upward trajectory after "a tough run the last few years." It has a ‘Neutral’ rating and a price target of $40.For the first quarter, the company reported revenue of $317 million, down 1.3% year-over-year but up 2.1% organically on a constant-currency basis. Adjusted earnings per share came in at $0.89. Both were ahead of the consensus estimates polled by Fiscal AI.<h2 class="st-heading-2">Needham Believes A Sale Makes Sense</h2>The firm thinks a Conmed sale makes sense given its mid-single-digit growth, "strong recurring revenue composition, and depressed valuation." Moreover, Needham said Conmed could be attractive to larger companies, with Zimmer Biomet (ZBH) making the most sense.Meanwhile, on Stocktwits, retail sentiment around CNMD stock remained in ‘bullish’ territory over the last 24 hours. <a href="https://stocktwits.com/symbol/CNMD">CNMD stock</a> is up more than 4% so far this year but down more than 15% over the last 12 months.For updates and corrections, email newsroom[at]stocktwits[dot]com

Rising stock market chart on a trading board background. (Source: Getty Images)

Shares of Conmed (CNMD) attracted significant investor attention on Monday after analysts commented on the reported buyout interest received by the medical technology company last week.

On Friday, a Bloomberg Law report indicated that the company is considering a sale after private equity investors expressed interest.


Nvidia ($NVDA) is moving lower after Jensen Huang resigned as CEO. Are you buying the dip?

Stocktwits

) is moving lower after Jensen Huang resigned as CEO. Are you buying the dip?

Current Price	$50.48
Prev Close	$50.77
Open	$51.43
Dividend Yield	1.48%
50-Day Moving Average	$47.14
Beta	0.81
Avg. Volume	420,885.21
PE Ratio	20.91

52-Week High	$54.80
52-Week Low	$31.44
Market Capitalization	$1.51B
EPS (Annual)	$1.51
Price to Book	1.42
Revenue Per Employee	$352,434.61

Feed

News

Sentiment

Earnings

Fundamentals

Info

CNMD Fundamentals